Ban on puberty suppressing hormones made indefinite

The Government has announced that the existing emergency measures banning the sale and supply of puberty suppressing hormones for the treatment of gender dysphoria or incongruence in under-18s have been made indefinite. NHS patients who are already receiving these medicines for gender dysphoria or incongruence can continue to access them, as can patients receiving the medicines for other uses.  For children and young people whose access to puberty suppressing hormones have been discontinued (for example, prescriptions from non-UK prescribers) and are not on the waiting list of children’s gender services, NHS England will offer a targeted support from local NHS mental health services. Children, young people and their families can access this service, which is being coordinated through NHS Arden and GEM Commissioning Support Unit, by contacting agem.cyp-gnrss@nhs.net.